| HOME >> MEDICINE >> TECHNOLOGY |
Table 21: Canada consumer price index (absolute), 2006–10 52
Table 22: Canada exchange rate, 2006–10 52
Table 23: France pharmaceuticals market value: $ million, 2006–10 54
Table 24: France pharmaceuticals market segmentation: % share, by value, 2010 55
Table 25: France pharmaceuticals market share: % share, by value, 2010 56
Table 26: AstraZeneca PLC: key facts 68
Table 27: AstraZeneca PLC: key financials ($) 70
Table 28: AstraZeneca PLC: key financial ratios 70
Table 29: GlaxoSmithKline Plc: key facts 72
Table 30: GlaxoSmithKline Plc: key financials ($) 74
Table 31: GlaxoSmithKline Plc: key financials (£) 75
Table 32: GlaxoSmithKline Plc: key financial ratios 75
Table 33: Pfizer Inc.: key facts 77
Table 34: Pfizer Inc.: key financials ($) 78
Table 35: Pfizer Inc.: key financial ratios 78
Table 36: France pharmaceuticals market value forecast: $ million, 2010–15 80
Table 37: France size of population (million), 2006–10 81
Table 38: France gdp (constant 2000 prices, $ billion), 2006–10 81
Table 39: France gdp (current prices, $ billion), 2006–10 81
Table 40: France inflation, 2006–10 82
Table 41: France consumer price index (absolute), 2006–10 82
Table 42: France exchange rate, 2006–10 82
Table 43: Germany pharmaceuticals market value: $ million, 2006–10 84
Table 44: Germany pharmaceuticals market segmentation: % share, by value, 2010 85
Table 45: Germany pharmaceuticals market share: % share, by value, 2010 86
Table 46: GlaxoSmithKline Plc: key facts 98
Table 47: GlaxoSmithKline Plc: key financials ($) 100
Table 48: GlaxoSmithKline Plc: key financials (£) 101
Table 49: GlaxoSmithKline Plc: key financial ratios 101
Table 50: Novartis AG: key facts 103
Table 51: Novartis
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |